Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Wolframin ER transmembrane glycoprotein (WFS1) is a protein encoded by the WFS1 gene, residing in the membrane of the endoplasmic reticulum. It plays a vital role in cellular calcium balance, ER stress regulation, unfolded protein response, and intracellular ion homeostasis. In the pancreas, it supports insulin production and secretion; in the nervous system and sensory organs, it modulates neuronal activities, hearing, and behavioral functions. Mutations in WFS1 are implicated in Wolfram syndrome, diabetes mellitus, neurodegeneration, and sensorineural hearing loss. WFS1 interacts with proteins such as SERCA, Sigma 1 receptor, and calmodulin, further supporting its regulatory functions within the ER. Dantrolene has shown experimental promise in ameliorating ER stress in WFS1-deficient models, but no approved drugs directly target WFS1 clinically.
Dantrolene: stabilizes ER calcium homeostasis, suppresses calpain activation by limiting abnormal calcium flux—protects ER and reduces stress-induced apoptosis in neural cell models
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Wolframin ER transmembrane glycoprotein (WFS1).